Register at Nccn.org/policy
Additional Background
NCCN previously held a summit on "Value, Access, Cost of Cancer Care" in New York on September 11, 2015 - here.
Value frameworks are plentiful - from ICER in Boston; from Sloan-Kettering (Drug Abacus, here), from ASCO, and elsewhere. See the ASCO Value Framework here. See also the organization and trade journal, Association for Value Based Cancer Care, here. For an article in The Oncologist, May 2016, see here. For an article at AJMC, here; for a review at the ZS pharma consultancy, here; for an article in Nature Reviews Drug Discovery, here. For an article by Jason Shafrin, here.
On September 15, Washington lawmakers introduced a bill "that would require drug makers to justify their pricing and provide a breakdown of their costs before raising prices...more than 10%;" here, here, here.
Addendum - November 16, 2016
Two other December 2016 Washington workshops of interest to oncology.
On December 12-13, 2016, the Institute of Medicine holds a workshop on "Drug Development Paradigm in Oncology." Here.
On December 13-14, 2016, IOM holds a workshop on "Ensuring Patient Access to Affordable Drug Therapies." Here. A prior session on this topic was held in November 2016; here. A post meeting report by Pink Sheet (subscription), here.
In November 2016, IOM released a 9 page brief on pain and opioid harms; here.
